The size of the European anti-snoring devices market was valued at USD 0.30 billion in 2021. It is further projected to be worth USD 0.50 billion by 2026, showcasing a CAGR of 10.86% during the forecast period.
Snoring is a common sleep disorder resulting from the repetitive narrowing and collapsing of the upper airway. Untreated snoring is often associated with adverse health outcomes, including systemic hypertension, coronary artery disease, stroke, and atrial fibrillation. In addition, snoring is also considered a significant social problem and leads to a more reduced quality of life for bed partners through disrupted sleep. Treatment for snoring involves either anti-snoring devices or doing an appropriate surgery. Conventional surgery includes uvulopalatopharyngoplasty surgery, tonsillectomy and adenoidectomy surgery, maxillo-mandibular and genioglossus advancement surgeries, radiofrequency ablation surgery.
A few of the key factors promoting the anti-snoring devices market in the European region are the increase in the awareness among individuals regarding the ill effects of snoring, soaring geriatric and obese population, the presence of an untapped population pool characterized by a snoring condition, and the increasing consumption of alcohol and cigarettes. The subsequent health risks associated with this condition are sleep apnea, interrupted breathing, and strain on the heart. These conditions have stimulated the population to opt for treatment solutions, including non-surgical appliances and surgical options, which has led to the overall industry's growth.
Be that as it may, such as the high cost of these surgeries, limited efficacy of the current treatments available for this condition, and unpropitious reimbursement issues are likely to deter the growth of anti-snoring devices and the snoring surgery market. Moreover, disadvantages to the use of the non-surgical equipment, such as dry mouth, jaw discomfort, and hypersalivation, serve as solid deterrents that discourage their use among the patients.
This research report on the European anti-snoring devices market has been segmented and sub-segmented into the following categories.
By Product Type:
By Surgical Procedures:
Geographically, the European anti-snoring devices market held the second-largest share in the global market during the forecast period. Factors such as growth in the awareness among individuals regarding the detrimental effects of this condition, the presence of many players in this sector, and an untapped population suffering from this condition are a few of the key factors boosting the market’s growth rate.
In 2020, the UK accounted for the majority market share in the European anti-snoring devices market. High intake of alcohol and cigarettes may reduce the blood flow to the ear, creating hearing impairments. The prevalence of the factor, as mentioned earlier, is high in Europe, which is predicted to drive market growth in the United Kingdom. In addition, technologically advanced new devices and therapeutics of the anti-snoring devices market are further accelerating the development of the UK anti-snoring devices.
The France Anti-snoring devices market is predicted to showcase a healthy CAGR due to increased intake of alcohol and cigarettes, unfavorable reimbursement policies, and high costs associated with the surgeries are majorly boosting the market growth. However, the custom-made oral devices may restrain the anti-snoring devices market growth. In addition, the elder people population is more in France followed by the UK, and an overweight population responsible for the snoring diseases and increasing awareness related to illness of snoring and related advantages is driving the market of anti-snoring devices growth.
KEY MARKET PLAYERS:
A few of the prominent companies leading the Europe anti-snoring devices market profiled in the report are Sleeping Well LLC., Apnea Sciences Corporation, Tomed Dr. Toussaint GMBH, AccuMED Corp, Fisher & Paykel Healthcare, Apnea Sciences Corporation, ImThera Medical Inc., ResMed Inc., SomnoMed, Sleep Well Enjoy Life, Ltd.., MEDiTAS Ltd and Nasal Devices.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.2 Oral Appliances/Mouthpieces
126.96.36.199 Mandibular Advancement Devices (MADS)
188.8.131.52.1 Non-Custom MADS
184.108.40.206.2 Custom-Made MADS
220.127.116.11 Tongue-Retaining Devices (TRDS)
"5.1.3 Nasal Devices
18.104.22.168 External Nasal Dilators (Nasal Strips)
22.214.171.124 Other Nasal Devices
5.1.4 Position Control Devices
5.1.5 Chin Straps
5.1.6 Tongue-Stabilizing Devices (TSDs)
"5.1.7 Epap Therapy Devices
5.1.8 Y-o-Y Growth Analysis, By Device Type
5.1.9 Market Attractiveness Analysis, By Device Type
5.1.10 Market Share Analysis, By Device Type
5.2 Surgical Procedures
5.2.2 Uvulopalatopharyngoplasty (UPPP)
5.2.3 Laser-Assisted Uvulopalatoplasty (Laup)
5.2.4 Radiofrequency Ablation (Somnoplasty)
5.2.5 Pillar Procedure
5.2.6 Injection Snoreplasty/Sclerotherapy
5.2.7 Palatal Stiffening Procedures
5.2.8 Other Anti-Snoring Surgical Procedures
5.2.9 Y-o-Y Growth Analysis, By TSurgical Proceduresype
5.2.10 Market Attractiveness Analysis, By Surgical Procedures
5.2.11 Market Share Analysis, By Surgical Procedures
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Device Type
184.108.40.206 By Surgical Procedures
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Device Type
22.214.171.124 By Surgical Procedures
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Device Type
184.108.40.206 By Surgical Procedures
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Sleeping Well LLC
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Apnea Sciences Corporation
8.3 Tomed Dr. Toussaint Gmbh
8.4 AccuMED Corp.
8.5 Fisher & Paykel Healthcare
8.6 Apnea Sciences Corporation
8.7 ImThera Medical Inc.
8.8 ResMed Inc.
8.10 Nasal Devices.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures